FCER1A and triple-A syndrome: Anti-FcεR1a mAb immunostaining demonstrated the anticipated accumulation of donor FcεR1a-positive BMMCs from Apoe−/− mice in Apoe−/−Fcer1a−/− recipient mouse AAA lesions (Supplementary Fig S8C and Fig 4A, left two panels).